Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease

被引：0
|
作者：
Aldred, J.
Henriksen, T.
Bouchard, M.
Martinez-Castrillo, J.
Soileau, M.
Spiegel, A.
Bergmann, L.
Gupta, R.
Kukreja, P.
Standaert, D.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
19
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Foslevodopa/Foscarbidopa in People with Parkinson's disease (PD) with and Without Care Partner Support
    Soileau, M.
    Bronstein, J.
    Harmer, L.
    Shah, M.
    Gupta, R.
    Metman, L. Verhagen
    MOVEMENT DISORDERS, 2024, 39 : S313 - S315
  • [22] Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Nukariya, Tomonori
    Tezuka, Toshiki
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2025,
  • [23] Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time
    Isaacson, S.
    Di Lorenzo, G.
    Facheris, M.
    Fung, V.
    Henriksen, T.
    Ikenaka, K.
    Jia, J.
    Kern, D.
    Kukreja, P.
    Santos Garcia, D.
    Spiegel, A.
    Zhang, Z.
    Bergmann, L.
    Carroll, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 444 - 445
  • [24] Continuous Subcutaneous Foslevodopa-Foscarbidopa in Parkinson's Disease: A Mini-Review of Current Scope and Future Outlook
    Aubignat, Mickael
    Tir, Melissa
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (10): : 1188 - 1194
  • [25] Stability and Predictability of Motor Symptom Control in Patients with Advanced Parkinson's Disease (aPD) Receiving Continuous Subcutaneous Foslevodopa/Foscarbidopa (LDP/CDP)
    Pahwa, R.
    Malaty, I.
    Soileau, M.
    Fung, V.
    Garcia, D. Santos
    Carroll, C.
    Henriksen, T.
    Epstein, A.
    Yan, C.
    Alobaidi, A.
    Shewale, A.
    Spiegel, A.
    Facheris, M.
    Shah, M.
    Kukreja, P.
    Zamudio, J.
    Chaudhuri, K.
    MOVEMENT DISORDERS, 2023, 38 : S44 - S45
  • [26] Improvement in Motor Symptoms and Quality of Life in Patients with an Earlier Stage of Advanced Parkinson's Disease Treated with Foslevodopa/Foscarbidopa Subcutaneous 24 Hour Infusion
    Antonini, A.
    Bergmans, B.
    Kern, D.
    Odin, P.
    Bergmann, L.
    Gupta, R.
    Homola, J.
    Shah, M.
    Zamudio, J.
    Standaert, D.
    MOVEMENT DISORDERS, 2023, 38 : S10 - S10
  • [27] Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Tezuka, Toshiki
    Nukariya, Tomonori
    Kizuka, Yuta
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (04) : 453 - 455
  • [28] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
    Aldred, Jason
    Freire-Alvarez, Eric
    Amelin, Alexander V.
    Antonini, Angelo
    Bergmans, Bruno
    Bergquist, Filip
    Bouchard, Manon
    Budur, Kumar
    Carroll, Camille
    Chaudhuri, K. Ray
    Criswell, Susan R.
    Danielsen, Erik H.
    Gandor, Florin
    Jia, Jia
    Kimber, Thomas E.
    Mochizuki, Hideki
    Robieson, Weining Z.
    Spiegel, Amy M.
    Standaert, David G.
    Talapala, Saritha
    Facheris, Maurizio F.
    Fung, Victor S. C.
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1937 - 1958
  • [29] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study
    Aldred, J.
    Amelin, A.
    Antonini, A.
    Bergmans, B.
    Bergquist, F.
    Bouchard, M.
    Budur, K.
    Carroll, C.
    Chaudhuri, K.
    Criswell, S.
    Danielsen, E.
    Alvarez, E. Freire
    Gandor, F.
    Jia, J.
    Kimber, T.
    Mochizuki, H.
    Robieson, W.
    Spiegel, A.
    Standaert, D.
    Talapala, S.
    Facheris, M.
    Fung, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 178 - 179
  • [30] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
    Jason Aldred
    Eric Freire-Alvarez
    Alexander V. Amelin
    Angelo Antonini
    Bruno Bergmans
    Filip Bergquist
    Manon Bouchard
    Kumar Budur
    Camille Carroll
    K. Ray Chaudhuri
    Susan R. Criswell
    Erik H. Danielsen
    Florin Gandor
    Jia Jia
    Thomas E. Kimber
    Hideki Mochizuki
    Weining Z. Robieson
    Amy M. Spiegel
    David G. Standaert
    Saritha Talapala
    Maurizio F. Facheris
    Victor S. C. Fung
    Neurology and Therapy, 2023, 12 (6) : 1937 - 1958
12345